Background: Conventional meta-analysis based on genetic markers may be less powerful for heterogeneous samples. In this study, we introduced a new meta-analysis for 4 genomewide association studies on alcohol dependence that integrated the information of putative causal variants.
A TRUE ASSOCIATION between a disease and a causal genetic variant usually is replicable across different (and even heterogeneous) populations, and the gene effects of this causal variant usually can be cumulated with increasing sample sizes. Conventionally, meta-analysis estimates the weighted average of effects of the same allele ("nucleotidebased") across different samples. When these effects have the same direction across different (but usually homogeneous) samples, they can be additive in meta-analysis, which results in a statistical power increase. However, if the gene effects have opposite directions in different (and usually heterogeneous) samples, or the gene effects are significant in one sample but nonsignificant in another, they will be neutralized in meta-analysis, which results in a statistical power decrease.
Between genetically heterogeneous populations, the allele frequencies of the same marker may be different. For example, we reported that 754,259 (75%) among 1 million single nucleotide polymorphisms (SNPs) were significantly (p < 10
À8
) different in allele frequency between European Americans and African Americans, and the minor alleles (f < 0.5) of 157,718 (16%) SNPs in European Americans were the major alleles (f > 0.5) in African Americans, and vice versa (see supplemental materials and methods by Zuo et al., (2012) ). Suppose the causal allele of a putative diseasecausal variant is a minor allele, it is expected that the risk allele of a marker in complete linkage disequilibrium with this causal allele would be a minor allele too, although this minor allele may be in opposite phases between European Americans and African Americans if this marker is among those 157,718 SNPs (Pei et al., 2012; Zuo et al., 2012) . The combined effects of the same allele of such a marker (i.e., rare in one population but common in another) across these 2 populations by meta-analysis will be neutralized, which results in information loss. However, the combined effects of the minor allele of such a marker between these 2 populations will be additive, although the minor alleles are different between them. Under this circumstance, meta-analysis based on minor alleles would be more powerful. The minor allele frequency (MAF) difference between any 2 populations should not exceed 0.5, so that the potential inflation effects of heterogeneity on meta-analysis can be limited, and thus, the heterogeneous samples might be able to be meta-analyzed. In this study, we combined the effects of minor alleles (not necessary to be the same alleles) across 4 data sets via metaanalysis, to search for risk markers for alcohol dependence. Although this new approach ("minor allele-based") is as reasonable as the conventional one ("nucleotide-based"), it is not necessary to be more powerful in all circumstances. It is also subject to the disadvantage of meta-analysis described above; that is, the gene effects significant in one sample but nonsignificant in another even though in the same direction or the gene effects of minor alleles with opposite directions between 2 samples will be averaged by weight and become less significant by meta-analysis. In other words, some of the combined effects across all data sets might not be more significant than those across some subsets. Thus, it is necessary to test within some subsets before meta-analyzing all cohorts.
MATERIALS AND METHODS

Subjects
A total of 12,481 subjects in 4 independent cohorts with alcohol dependence (DSM-IV) from dbGaP were analyzed, including 1 European American Study of Addiction: Genetics and Environment (SAGE) + Collaborative Study on the Genetics of Alcoholism (COGA) cohort (1,409 cases with alcohol dependence and 1,518 controls), 1 European Australian Alcohol Research using Australian twins and their families (OZ-ALC) cohort (a total of 6,438 family subjects with 1,645 alcohol dependent probands), 1 African American SAGE + COGA cohort (681 cases and 508 controls), and 1 African American Yale cohort (1,429 cases and 498 controls). SAGE and COGA cohorts were merged because their samples overlapped and were genotyped on the same platform. Subjects from the SAGE, COGA, and OZ-ALC cohorts were interviewed using the Semi-Structured Assessment for the Genetics of Alcoholism (Bucholz et al., 1994) , and subjects from the Yale cohort were interviewed using the Semi-Structured Assessment for Drug Dependence and Alcoholism (Pierucci-Lagha et al., 2005) . Affected subjects met lifetime DSM-IV criteria for alcohol dependence (American Psychiatric Association, 1994) . The control subjects were defined as individuals who had been exposed to alcohol (and possibly to other drugs), but had never become addicted to alcohol or other illicit substances (lifetime diagnoses). All subjects gave written informed consent to participating in protocols approved by the relevant institutional review boards (IRBs). All subjects were de-identified in this study that was approved by Yale IRB. Detailed demographic information for these cohorts is shown in Table 1 or is available elsewhere Edenberg et al., 2010; Heath et al., 2011; Zuo et al., 2009 Zuo et al., , 2011 Zuo et al., , 2012 Zuo et al., , 2013a .
Genotyping and Imputation
The SAGE + COGA, OZ-ALC, and Yale cohorts were genotyped on the Illumina Human 1M beadchip (with 1 million SNPs; Illumina, Inc., San Diego, CA), the Illumina CNV370v1 beadchip (with 370,000 SNPs), and the Illumina HumanOmni1_Quad_v1-0_B beadchip (with 1 million SNPs), respectively. To make the genetic marker sets highly consistent across the different cohorts, we imputed the untyped SNPs in all samples based on the same reference panels. We used the following strategies to maximize the success rate and accuracy of imputation. (i) We used both 1,000 Genome Project and HapMap 3 panels as the reference. The CEU (CEPH Europeans) and YRI (Yoruba Africans) panels from these panels were used to impute untyped SNPs in European-origin samples and African-origin samples, respectively. Only the genotypes that were consistently imputed from these 2 independent reference panels were selected for analysis. (ii) We used a Markov chain Monte Carlo algorithm implemented in the program IMPUTE2 (Howie et al., 2009 ) to derive full posterior probabilities (i.e., not the "best-guess") of the genotypes of each SNP to minimize the inference bias. (iii) We set the imputation parameters at burnin = 10,000, iteration = 10,000, k = 100, Ne = 11,500, and confidence level = 0.99 when using IMPUTE2 (Howie et al., 2009) ; that is, the uncertainty rate of inference was <1%. (iv) Because the imputation process using IMPUTE2 did not incorporate the family relationship information, Mendelian errors might occur in the imputed data. Thus, the families with at least 1 individual who had more than 0.5% Mendel errors (considering all SNPs tested) and the SNPs with more than 0.5% Mendel errors (considering all individuals tested) were excluded. Meanwhile, we also used the program BEAGLE (Browning and Browning, 2009 ) to impute genotypes independently. The imputation process using BEAGLE does incorporate the family relationship information. Only the imputed genotypes that were consistently imputed by both IMPUTE2 and N, sample size. In the European-Australian family data, only the affected and unaffected offspring are listed.
BEAGLE were selected for analysis. And (v) we stringently cleaned the imputed genotype data after imputation. Furthermore, only the SNPs that had similar MAFs (with frequency difference <0.2%) in the healthy controls across different cohorts and HapMap database (within the same ethnicity) were selected for analysis. After this strict selection, we were highly confident with the quality of these imputed genotype data. Finally, for SNPs that were directly genotyped, we used the direct genotypes rather than the imputed.
Data Cleaning
We stringently cleaned the phenotype and genotype data before the association analysis. Subjects with poor genotypic data, allele discordance, sample relatedness, gender anomalies, chromosome anomalies (such as aneuploidy and mosaic cell populations), missing race, population group outliers, a mismatch between self-identified and genetically inferred ethnicity, or a missing genotype call rate ≥2% across all SNPs were excluded. Furthermore, SNPs with allele discordance, chromosomal anomalies, or batch effect were also excluded. We then filtered out the SNPs on all chromosomes with an overall missing genotype call rate ≥2%, the monomorphic SNPs, and the SNPs with MAFs <0.01. The SNPs that deviated from HardyWeinberg equilibrium (p < 10
À4
) within controls were also excluded.
Association Test
The genomewide association analysis was performed using logistic regression implemented in PLINK (Purcell et al., 2007) for each case-control cohort or using FBAT for the familybased cohort (Laird et al., 2000) . Diagnosis and alleles each served as the dependent and independent variables, respectively, with sex, age, and the first 10 principal components of ancestries as covariates. The principal component scores of our samples were derived from all autosomal SNPs across the genome using principal component analysis implemented in the software package EIGENSTRAT (Price et al., 2006) . Each individual received scores on each principal component. These principal components reflected the population structure of our samples. The first 10 principal component scores accounted for >90% of variance. These principal components when included as covariates in the model can control for the population stratification and admixture effects on association analysis. The p-values derived from these association analyses are illustrated in Fig. 1 or elsewhere (Zuo et al., 2011 (Zuo et al., , 2012 (Zuo et al., , 2013b . The genomewide Bonferroni-corrected a was set at 5 9 10 À8 (by 1 million markers). The odds ratios (ORs) from regression analyses and the Z scores from FBAT analysis were also derived. The directions of ORs and Zs were incorporated into the meta-analysis.
Meta-Analysis
Meta-analysis was performed to derive the combined p-values between cohorts using the program METAL (Willer et al., 2010) . We recoded the minor allele of each SNP to "minor" and the major allele to "major," regardless of whether the minor alleles were the same ones in different samples or not, which is the major difference from the conventional meta-analysis. After this recoding, the maximal difference of MAF among all control cohorts was 0.324 (=0.420-0.096 for rs11583322^C) in this study, much less than 0.518 (=0.720-0.202 for rs350660^C) before recoding (Table 2 ). An overall z-statistic and an overall p-value for each SNP were calculated from a weighted sum of the individual statistics. Weights were propor- tional to the square root of the number of individuals examined in each cohort and selected such that the squared weights sum to 1.0 (Willer et al., 2010) . We tested meta-analysis for 2 cohorts with European ethnicity, 2 cohorts with African ethnicity, and globally for all 4 cohorts. Heterogeneity indexes (I 2 ) were calculated for all meta-analyses using the program PLINK (Purcell et al., 2007) .
cis-Acting Expression of Quantitative Locus Analysis
To examine relationships between all risk SNPs and local mRNA expression levels, we examined the expression data in human lymphoblastoid cell lines from 270 unrelated HapMap individuals (Stranger et al., 2005) . Differences in the distribution of mRNA expression levels between SNP genotypes were compared using a Wilcoxon-type trend test. We also examined the expression data in 93 autopsy-collected frontal cortical brain tissue samples with no defined neuropsychiatric condition and 80 peripheral blood mononuclear cell (PBMC) samples collected from living healthy donors (Heinzen et al., 2008) . Differences in the distribution of mRNA expression levels between SNP genotypes were analyzed using a linear regression model by correcting for age, sex, source of tissues, and principal component scores. This cis-acting expression of quantitative locus (cis-eQTL) analysis served as functional validation for our association findings.
Rat Brain Transcriptome Analysis
We generated RNA-Seq data from total RNA (after ribosomal RNA depletion) in brains of 2 inbred strains of rats (BN-Lx/CubPrin and SHR/OlaPrin) (Bhave et al., 2007) . After reads were trimmed for adapters and quality, they were aligned to the RGSC5.0/rn5 version of the rat genome using TopHat2 (Kim et al., 2013) . RNA expression was quantitated for Ensembl genes using CuffLinks (Trapnell et al., 2010) . Read fragments per kilobase of transcript per million reads (FPKM) for each strain are reported. This animal study also served as functional validation for our association findings.
RESULTS
The inflation factor (k) from QQ plots for genomewide p-values in these 4 cohorts was 1.07, 1.03, 1.01, and 1.06, respectively (Zuo et al., 2011 (Zuo et al., , 2012 (Zuo et al., , 2013b (Fig. 1) , which indicated that the population stratification effects have been successfully controlled. Before meta-analysis, we found 10 top-ranked (p < 10
À6
) risk markers associated with alcohol dependence in European Americans (SAGE + COGA) and 1 in African Americans (Yale). These risk markers were located at SERINC2 (2.3 9 10 À7 ≤ p ≤ 4.4 9 10 À7 ), STK40 (p = 4.0 9 10 À7 ), KIAA0040 (2.9 9 10 À7 ≤ p ≤ 4.0 9 10 À7 ), and IPO11 (p = 2.8 9 10 À7 ) in European Americans (Zuo et al., 2012) , and PLD1 (phosphatidylcholine-specific phospholipase D1) (p = 8.3 9 10
À7
; OR = 1.56) in African Americans (data not shown).
In meta-analysis of European American and European Australian cohorts, we found 10 top-ranked SNPs (p < 10
À6
) that were associated with alcohol dependence. They included 6 at SERINC2 (3.1 9 10 À8 ≤ p ≤ 9.6 9 10 À8 ) (Zuo et al., 2013b) , 1 at STK40 (p = 1.3 9 10 À7 ), 2 at KIAA0040 (3.3 9 10 À7 ≤p ≤ 5.2 9 10 À7 ), and 1 at IPO11 (p = 6.9 9 10 À7 ). Except for the one at IPO11 that was nominally significant in meta-analysis of African cohorts (p = 2.2 9 10 À2 ) but had opposite effect to that in Europeans, all other 9 associations were not significant in African American cohorts, so that adding African American cohorts into the meta-analysis did not increase the power. In metaanalysis of 2 African American cohorts, we found 2 topranked SNPs (p < 10
) that were associated with alcohol dependence. They included 1 at SLC6A11 (p = 2.7 9 10 À7 ) and 1 at CBLN2 (p = 7.4 9 10 À7 ). These associations were not significant in European cohorts, so that adding European cohorts into the meta-analysis did not increase the power either. In meta-analysis of all 4 cohorts, we found 2 top-ranked SNPs (p < 10
) that were associated with alcohol dependence. They both were located in PTP4A1-PHF3 locus (6.0 9 10 À7 ≤ p ≤ 7.2 9 10 À7 ). These 2 SNPs were nominally associated with alcohol dependence both in European cohorts (1.8 9 10 À3 ≤ p ≤ 2.4 9 10
À3
) and in African cohorts (1.6 9 10 À5 ≤ p ≤ 2.0 9 10
À5
), but their risk alleles were in opposite phases between Europeans and Africans. Compared with the conventional approach based on risk alleles, our new approach based on minor alleles reduced about 25% of the maximal frequency difference of the target alleles among all control cohorts and about 10% of the heterogeneity index (I 2 ) when meta-analyzing these 2 SNPs across all cohorts (data not shown). After correction for multiple testing (a = 5 9 10 À8 ), 3 associations at SERINC2 remained significant and others remained suggestively significant (Table 3) .
Significant cis-eQTL signals were presented in Table 3 . cis-eQTL analysis showed that rs4478858 at SERINC2 had significant regulatory effect on the expression of SERINC2 transcript both in human brain (p = 0.024) and in PBMC sample (p = 0.026) (Zuo et al., 2013b ). Rs350660 at SLC6A11 had significant regulatory effect on the expression of SLC6A11 transcript in the PBMC sample (p = 0.016). Rs1057239 (p = 0.011) and rs1894709 at KIAA0040 (p = 0.008), rs6942342 at PTP4A1 (p = 0.008), rs7652788 at PLD1 (p = 0.023), and rs9294269 at PHF3 (p = 0.002) had significant regulatory effects on the expression of local transcripts in HapMap samples (Table 3) .
All of the aforementioned risk genes except for KIAA0040 have orthologous genes in rat. They were expressed above background in brain (FPKM >1) of both inbred rat strains assessed (Table 4 ). The transcript for KIAA0040 which is not thoroughly annotated in the human genome was not distinguishable among the RNAs expressed in rat brain.
DISCUSSION
In the present study, we found multiple genes that were significantly or suggestively associated with alcohol dependence. Ten associations at 4 genes (SERINC2, STK40, KIAA0040, and IPO11) were European specific. Two associations at 2 genes (SLC6A11 and CBLN2) were African specific. Two associations at PTP4A1-PHF3 locus were suggestively significant in both Europeans and Africans. The gene products of SERINC2, CBLN2, SLC6A11, IPO11, and PTP4A1 are all components of cellular membranes that can be enriched by David Functional Annotation Clustering Tool (Huang da et al., 2007) . Additionally, 1 association at PLD1 was cohort specific that needed further validation in more cohorts in the future. These genes are among the most appropriate for follow-up as contributors to risk for alcohol dependence.
Most genetic risk markers are not the disease-causal variants per se, so that the allele frequencies of genetic risk markers may not be completely consistent with the causal EA, European Americans; EAu, European Australians; AA, African American SAGE + COGA cohorts; AA (Yale), African American Yale cohort; P, pvalue of meta-analysis; Z, Z scores; TFBS, these single nucleotide polymorphisms (SNPs) are located in the transcription factor binding sites; ESS, this marker is located in an exonic splicing silencer or enhance; CpG, these SNPs are located within CpG islands; CNV, these SNPs are located within methylated CNVs (see UCSC Genome Browser); eQTL, this SNP has significant transcript-level cis-eQTL signal (p < 0.05) in brain, peripheral blood mononuclear cell (PBMC) or lymphoblastoid cell tissue.
Meta-analysis with p > 10 À6 is not shown in this table.
variants. These allele frequencies could vary among different populations due to the different histories of evolution. It is not necessary that the same alleles are associated with causal alleles in different populations when these alleles have different frequencies among them. Taking the alleles with similar frequencies in different populations (called the putative causal alleles in the context), instead of the same allele, as the risk allele could be reasonable. In this case, combining the effects of alleles of the putative causal variants, instead of those of the markers per se, could be an alternative reasonable and powerful strategy for meta-analysis. Our findings from this strategy on SERINC2, KIAA0040, STK40, IPO11, and PTP4A1-PHF3 were generally consistent with previous reports that used genomewide association analysis (Zuo et al., 2011 (Zuo et al., , 2012 (Zuo et al., , 2013a and conventional strategies for meta-analysis . We previously reported that rare variant constellation across SERINC2 was specific to alcohol dependence in European-origin populations (Zuo et al., 2013c) , which is consistent with the current findings using common variants. Specifically pointing out here that the minor alleles of PTP4A1-PHF3 SNPs were opposite between European Americans and African Americans. Only our meta-analysis using this new strategy detected association signals with p < 10 À6 in PTP4A1-PHF3 region that a previous report ignored (Zuo et al., 2011) . Furthermore, 2 novel top-ranked risk genes including SLC6A11 (GABA transporter) and CBLN2 (cerebellin 2 precursor) were also identified. Bioinformatics analysis showed that all of these top-ranked risk SNPs were located in the transcription factor binding sites (http://brainarray.mbni.med.umich.edu/Brainarray/Database/SearchSNP/snpfunc.aspx). Many of them were located within methylated CpG islands, within copy number variations, and/or had significant cis-eQTL signals in brain, PBMC, or lymphoblastoid cell tissue (Table 3) , suggesting that they may be functional.
As the propensity to develop alcohol dependence or other addictions is considered to be a component of brain function, we assessed the expression of RNA from each of the risk genes in brain of 2 strains of rats using RNA-Seq technology for measuring total RNA. The results from all of our measurements are available on http://phenogen.ucdenver.edu.
Keeping in mind the caveat that expression in rat brain may not wholly mimic the expression of transcripts in brain of humans, we found that 8 of the 9 risk genes were expressed in rat brain. We also verified that the same 8 genes were also expressed above background in mouse brain (data not shown; ERP000614).
The first observation generated from our gene expression studies in rat brain was the large difference in the expression of the Serinc2 gene product between the 2 strains of rats (one of which consumes 29 the alcohol as the other in a 2-bottle choice paradigm) (Tabakoff et al., 2009 ). In studies with humans, several SNPs across the length of this gene were significantly associated with alcohol dependence in European Americans and European Australians (Zuo et al., 2013b) . One could speculate that the involvement of SERINC2 in the etiology of alcohol dependence may be related to its expression levels. The Serinc proteins are critical in the regulation of lipid biosynthesis in brain, particularly phosphatidylserine and sphingolipids. Serinc2 is localized primarily to neurons and the activity of Serinc in neurons may be coupled to glutamatergic transmission (Inuzuka et al., 2005 ) (i.e., phosphatidylserine levels in neuron membranes modulate glutamate release; Yang and Wang, 2009 ). Slc6a11 was also highly expressed in rat brain, and although one cannot ascertain from our meta-analysis whether the product of this gene is differentially expressed in humans, or structural variants are possible, it is important to note that the SLC6A11 gene product is a GABA transporter located in astrocytes, as well as neurons (Itouji et al., 1996) , and is of importance in reducing synaptic and extrasynaptic levels of GABA (Song et al., 2013) . It is clear in studies of humans (Covault et al., 2004; Edenberg and Foroud, 2006) and animals (Tabakoff et al., 2009 ) that GABA neurotransmitter function is intimately related to alcohol dependence, but studies differ on which aspect of the GABA signal may vary with regard to alcohol dependence. It should also be noted that the product of the PTP4A1 gene was previously assessed by in situ hybridization in brains of humans. The PTP4A1 transcript showed a disparate distribution in the 2 tested brain areas (Dumaual et al., 2006) . Little or no PTP4A1 RNA was found in the "cerebral cortex," but moderate expression was noted in the cerebellum granule cell layer. Our measures in the whole brain of the rat, however, indicated robust expression of this dual specificity phosphatase, the protein product of which localizes to neuronal membranes, but signals through cAMP-dependent transcription factors (Rios et al., 2013) . Pld1 and Cbln2 were also expressed in both strains of rat brains. PLD1 encodes the phosphatidylcholine-specific phospholipase D (PLD) which catalyzes the hydrolysis of phosphatidylcholine to yield phosphatidic acid and choline. PLD has a high affinity for short chain alcohols (100-to 1,000-fold higher than for water). In the presence of ethanol, it promotes a transphosphatidylation reaction, with the production of phosphatidylethanol (PEth). The expression of PEth in blood is a direct marker of chronic alcohol use and abuse (Viel et al., 2012) . CBLN2 encodes a cerebellin 2 precursor. RNA-Seq was used for measuring the presence of the gene products in rat brain.
Cerebellin 2 is a secreted glycoprotein and may serve as a transneuronal cytokine involved in the regulation of synapse development and synaptic plasticity in various brain regions. CBLN2 has been associated with alcohol dependence in a genomewide association study (GWAS) (Lydall et al., 2011) . These genes are more likely to be the contributors to risk for alcohol dependence. Their mechanisms underlying these contributions are worth of more follow-up investigation.
